首页> 美国卫生研究院文献>International Journal of Molecular Sciences >FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
【2h】

FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease

机译:日本非酒精性脂肪肝患者的FIB-4指数和糖尿病与慢性肾脏病相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Non-alcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). The aim of this retrospective study was to determine the risk factors for progression of CKD in patients with biopsy-proven NAFLD including patatin-like phospholipase domain containing 3 (PNPLA3) polymorphism. A total of 344 patients with biopsy-proven NAFLD were enrolled consecutively in this study. Multivariate analysis identified males (odds ratio (OR) 5.46), age (per 1 year, OR 1.07), and FIB-4 index (≥1.30, OR 3.85) as factors associated with CKD. Of the 154 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min, 30 had a deterioration in CKD stage and 15 developed CKD after 3 years. Multivariate analysis identified diabetes mellitus (OR 2.44) as a risk factor for deterioration in CKD stage, while diabetes mellitus (OR 21.54) and baseline eGFR (per 1 mL/min OR 0.88) were risk factors for development of CKD. PNPLA3 did not affect the change in eGFR. In NAFLD patients, a high FIB-4 index was associated with CKD to increases in the index linked to reductions in eGFR. In order to prevent development of CKD, an appropriate therapy focusing on renal function is needed for NAFLD patients, especially those with diabetes.
机译:非酒精性脂肪肝疾病(NAFLD)与慢性肾脏病(CKD)相关。这项回顾性研究的目的是确定经活检证实为NAFLD的患者CKD进展的危险因素,包括含有3(PNPLA3)多态性的patatin样磷脂酶结构域。该研究共纳入344例经活检证实的NAFLD患者。多变量分析确定男性(优势比(OR)为5.46),年龄(每1年,OR为1.07)和FIB-4指数(≥1.30,OR 3.85)为与CKD相关的因素。基线估计肾小球滤过率(eGFR)≥60 mL / min的154例患者中,有30例在CKD阶段恶化,15例在3年后发展为CKD。多变量分析确定糖尿病(OR 2.44)是CKD恶化的危险因素,而糖尿病(OR 21.54)和基线eGFR(每1 mL / min或0.88)是CKD发生的危险因素。 PNPLA3不影响eGFR的变化。在NAFLD患者中,高FIB-4指数与CKD相关,该指数增加与eGFR降低有关。为了防止CKD的发展,NAFLD患者(尤其是糖尿病患者)需要针对肾脏功能的适当治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号